Company / Working Capital per Share
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$1.01
FY2025
5-year range
$1.01 / $5.04
FY2021-FY2025
Trend
-32.3%
vs FY2024
Sector context
#128 of 158
Health Care
What the data says
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s working capital per share of $1.01 is lower than 81% of companies in the Health Care sector (FY2025). Working Capital per Share has declined for 4 consecutive years, from $5.04 in FY2021 to $1.01 in FY2025.
Based on SEC 10-K filings.
1.01 in FY2025 with a 5-year CAGR of -11.1%.
Declined from $2.55 to $1.01 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -27.3%
- 5-Year CAGR
- -11.1%
- 10-Year CAGR
- -
Sector benchmark
-95.9% below sector average
Key checks
Key Insights
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s working capital per share has declined for 4 consecutive years.
- In FY2025, working capital per share decreased 32.3% year-over-year.
- Ranks #128 out of 158 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.01 | -32.3% |
| FY2024 | $1.49 | -41.6% |
| FY2023 | $2.55 | -2.7% |
| FY2022 | $2.62 | -48.0% |
| FY2021 | $5.04 | +178.3% |
| FY2020 | $1.81 | +766.7% |
| FY2019 | $0.21 | -76.8% |
| FY2018 | $0.90 | +14.4% |
| FY2017 | $0.79 | -16.3% |
| FY2016 | $0.94 | -3.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026